Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares iBoxx $ High Yield Corporate Bond ETF (HYG) vs ImmunityBio Inc. Common Stock (IBRX) Price & Performance

iShares iBoxx $ High Yield Corporate Bond ETFTrade
ImmunityBio Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

iShares iBoxx $ High Yield Corporate Bond ETF vs ImmunityBio Inc. Common Stock — how do they compare? iShares iBoxx $ High Yield Corporate Bond ETF trades at $77.17 (market cap $17.89B), while ImmunityBio Inc. Common Stock trades at $10.3 (market cap $10.51B). The key difference: iShares iBoxx $ High Yield Corporate Bond ETF is the larger of the two by market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, iShares iBoxx $ High Yield Corporate Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares iBoxx $ High Yield Corporate Bond ETF for 59 Days and ImmunityBio Inc. Common Stock for 0 Days on average.

HYGIBRX
Market Cap
$17.89B$10.51B
Volume
44,866,59210,445,785
Sector
Fixed IncomeHealth
52-Week High
$81.28$11.55
52-Week Low
$76.90$1.98
Typical Hold Time
59 Days0 Days
Enterprise Value
—$10.97B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares iBoxx $ High Yield Corporate Bond ETF

HYG (iShares iBoxx $ High Yield Corporate Bond ETF) trades at $77.115, down 0.08% with a bearish technical signal from moving averages. The fund has shown unusual options activity recently amid a challenging bond market environment where Treasury yields have reached multi-year highs. Recent dividend payments of $0.34-$0.44 per share provide income support, but the overall technical picture remains weak with significant selling pressure.

The outlook for HYG remains challenged by rising interest rates and bond market volatility. While the fund offers attractive yield income through regular dividends, the bearish technical momentum and elevated Treasury yields create headwinds for price appreciation. Key risks include further rate hikes and credit spread widening in the high-yield bond market.

ImmunityBio Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HYG
57% Buy43% Sell
Avg holding period · 59 Days
IBRX
100% Buy0% Sell
Avg holding period · 0 Days

About iShares iBoxx $ High Yield Corporate Bond ETF

HYG is the world's largest high-yield bond ETF, tracking the Markit iBoxx USD Liquid High Yield Index. It provides liquid exposure to non-investment grade corporate debt, with 2026 top holdings including Cloud Software Group and Medline.

Read more on HYG →

About ImmunityBio Inc. Common Stock

ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.

Read more on IBRX →